AMENDMENT NO. 3 TO THE SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 31st, 1997 • Creative Biomolecules Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 31st, 1997 Company Industry
3 - 4 Applications and the patents and applications that have been prosecuted in Stryker's name during the period from May 17, 1991 to October 31, 1996 as Future Patents and Applications (as defined below), a list of which is set forth in Schedule I...Amendment Agreement • March 31st, 1997 • Creative Biomolecules Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 31st, 1997 Company Industry
1 EXHIBIT 10.37 CREATIVE BIOMOLECULES, INC. HAS OMITTED FROM THIS EXHIBIT 10.37 PORTIONS OF THE AGREEMENT FOR WHICH CREATIVE BIOMOLECULES, INC. HAS REQUESTED CONFIDENTIAL TREATMENT FROM THE SECURITIES AND EXCHANGE COMMISSION. THE PORTIONS OF THE...Research Collaboration and License Agreement • March 31st, 1997 • Creative Biomolecules Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 31st, 1997 Company Industry
2 - 3 2.2 Registration Rights Agreement. The Second Amended and Restated Registration Rights Agreement, dated as of May 24, 1996, by and among the Company and various holders of the Company's securities (the "Registration Rights Agreement") shall have...Restricted Stock Purchase Agreement • March 31st, 1997 • Creative Biomolecules Inc • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledMarch 31st, 1997 Company Industry Jurisdiction